(Q27638993)

8

object named as

Irene T Weber

0 references

author name string

Bhuvaneshwari Mahalingam

1

0 references

Peter Boross

2

0 references

Yuan-Fang Wang

3

0 references

John M Louis

4

0 references

Christopher C Fischer

5

0 references

Robert W Harrison

Prevalence of drug resistant mutants and virological response to combination therapy in patients with primary HIV-1 infection.

7

0 references

language of work or name

English

0 references

publication date

1 July 2002

0 references

published in

Proteins

0 references

volume

48

0 references

issue

1

0 references

page(s)

107-16

0 references

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Multiple concurrent reverse transcriptase and protease mutations and multidrug resistance of HIV-1 isolates from heavily treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Phenotypic and genotypic analysis of clinical HIV-1 isolates reveals extensive protease inhibitor cross-resistance: a survey of over 6000 samples.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Ordered accumulation of mutations in HIV protease confers resistance to ritonavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Human immunodeficiency virus type 1 protease cleavage site mutations associated with protease inhibitor cross-resistance selected by indinavir, ritonavir, and/or saquinavir

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Retracing the evolutionary pathways of human immunodeficiency virus type 1 resistance to protease inhibitors: virus fitness in the absence and in the presence of drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Structural and kinetic analysis of drug resistant mutants of HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Drug resistance mutations can effect dimer stability of HIV-1 protease at neutral pH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Influence of flanking sequences on the dimer stability of human immunodeficiency virus type 1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Structural basis for specificity of retroviral proteases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Inhibition of porcine pepsin by two substrate analogues containing statine. The effect of histidine at the P2 subsite on the inhibition of aspartic proteinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Processing of X-ray diffraction data collected in oscillation mode

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

AMoRe: an automated package for molecular replacement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Improved methods for building protein models in electron density maps and the location of errors in these models

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

An analysis of conformational changes on protein-protein association: implications for predictive docking.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Objective comparison of protein structures: error-scaled difference distance matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Crystal structure of an in vivo HIV-1 protease mutant in complex with saquinavir: Insights into the mechanisms of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Crystallographic analysis of human immunodeficiency virus 1 protease with an analog of the conserved CA-p2 substrate -- interactions with frequently occurring glutamic acid residue at P2' position of substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Structure of the protease from simian immunodeficiency virus: complex with an irreversible nonpeptide inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Programming the Rous sarcoma virus protease to cleave new substrate sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Drug-resistant HIV-1 proteases identify enzyme residues important for substrate selection and catalytic rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140

Studies on the symmetry and sequence context dependence of the HIV-1 proteinase specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.10140